CYTOKINETICS, INCORPORATED Other Current Liabilities
CYTOKINETICS, INCORPORATED (CYTK) had Other Current Liabilities of $3.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Current $3.30M.
- 2026-03-31: Other Liabilities, Current $8.59M.
- 2025-12-31: Other Liabilities, Current $3.83M.
- 2025-09-30: Other Liabilities, Current $1.99M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.30M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.59M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $3.83M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.99M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $9.59M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $5.82M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $9.81M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $5.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $10.27M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $6.01M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $10.56M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $13.74M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $5.88M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $7.97M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.12M 10-K · filed 2024-02-28 | $2.08M 10-K · filed 2023-03-01 |
| 2022-09-30 | $5.78M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $1.76M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $3.04M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $1.54M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $2.41M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $2.44M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $1.05M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $2.41M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.01M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $2.51M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.12M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $389.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $399.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $75.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $66.00K 10-K · filed 2020-03-04 | |
| 2018-09-30 | $38.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $28.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $235.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $227.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $424.00K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $474.00K 10-Q · filed 2017-08-04 | |
| 2016-12-31 | $415.00K 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |